The recent outbreak of Bundibugyo virus disease (BVD) in the Democratic Republic of the Congo and Uganda is a cause for serious concern and has rapidly evolved into a complex public health crisis. As of my last update, the situation is evolving rapidly, with increasing case numbers and geographic spread, highlighting the urgent need for a comprehensive and coordinated response.
A Rapidly Evolving Outbreak
The BVD outbreak has seen a significant rise in cases, with a total of 906 suspected cases and 223 deaths reported in the Democratic Republic of the Congo alone. Additionally, 134 confirmed cases, including nine in Uganda, have been reported across both countries. This rapid increase in cases is a stark reminder of the virus's potential for rapid transmission and its deadly impact.
Geographic Spread and Cross-Border Transmission
One of the most concerning aspects of this outbreak is its geographic spread. Transmission is concentrated in Ituri Province, but cases have also been reported in North Kivu and South Kivu provinces in the Democratic Republic of the Congo. This spread across multiple provinces complicates response efforts and highlights the need for a coordinated approach at both the national and regional levels.
Furthermore, the ongoing cross-border transmission between the Democratic Republic of the Congo and Uganda is a significant challenge. As of my last update, nine confirmed cases have been reported in Uganda, including one death. This cross-border transmission underscores the importance of enhanced cross-border collaboration and surveillance to prevent further regional spread.
Challenges in Response Efforts
The response to the BVD outbreak is facing several challenges. In the Democratic Republic of the Congo, contact tracing and follow-up, as well as inadequate isolation, care, and referral systems for patients, are complicating efforts. Additionally, security incidents against health facilities and community resistance have emerged as major operational challenges in Ituri Province, creating additional risks for undetected transmission and disrupting response efforts.
Public Health Measures and International Support
Health authorities in both countries, in collaboration with the World Health Organization (WHO) and partners, are implementing comprehensive public health measures. These include the deployment of rapid response teams, the delivery of medical supplies, strengthened surveillance, laboratory confirmation, infection prevention and control measures, and the establishment of safe treatment centers. Community engagement is also a key focus to ensure effective response and prevention efforts.
The WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, traveled to the Democratic Republic of the Congo on May 28 to support the ongoing response, highlighting the international community's commitment to addressing this outbreak.
Epidemiology and Transmission
BVD is a severe and often fatal form of Ebola disease caused by the Bundibugyo virus. It is a zoonotic disease, with fruit bats suspected to be the natural reservoir. Human infection occurs through close contact with infected wildlife or contaminated surfaces, and subsequent person-to-person transmission is facilitated by inadequate infection prevention and control measures, particularly in healthcare settings, and unsafe burial practices.
The incubation period for BVD ranges from 2 to 21 days, and early symptoms are non-specific, making clinical diagnosis challenging and potentially delaying detection. Case fatality rates in past BVD outbreaks have ranged from approximately 30% to 50%, emphasizing the urgency of rapid case identification, isolation, and care.
WHO Risk Assessment and Advice
On May 22, 2026, the WHO assessed the risk of the BVD outbreak as very high at the national level in the Democratic Republic of the Congo, high at the regional level, and low at the global level. This risk assessment will be continuously reassessed as new information becomes available.
The WHO has issued temporary recommendations to States Parties, emphasizing the importance of coordinated outbreak control, enhanced cross-border collaboration, and sustained surveillance and preparedness. The WHO advises against any restriction of travel or trade based on the currently available information and continues to monitor and verify travel and trade measures related to this outbreak.
Conclusion
The BVD outbreak in the Democratic Republic of the Congo and Uganda serves as a stark reminder of the ongoing threat posed by emerging infectious diseases. The rapid evolution of this outbreak, its geographic spread, and the challenges faced in response efforts highlight the need for a robust and coordinated public health response. International collaboration, rapid case identification, and effective community engagement are crucial to controlling this outbreak and preventing further regional spread. As we navigate this complex situation, it is essential to remain vigilant, adaptive, and committed to protecting public health.
